LifeVantage to Announce Second Quarter Fiscal Year 2025 Results on February 5, 2025
LifeVantage (LFVN), a health and wellness company focusing on cellular health products, has announced it will release its second quarter fiscal 2025 financial results on February 5, 2025, after market close. The company will host a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) on the same day.
Investors can participate in the live call by dialing (877) 704-4453 from the U.S. or (201) 389-0920 internationally. A replay will be available until February 19, 2025, accessible by dialing (844) 512-2921 (U.S.) or (412) 317-6671 (international) with confirmation code 13750382. A simultaneous webcast will be available on the company's Investor Relations website, with a 30-day archive period.
LifeVantage (LFVN), un'azienda nel settore della salute e del benessere focalizzata sui prodotti per la salute cellulare, ha annunciato che rilascerà i suoi risultati finanziari per il secondo trimestre fiscale 2025 il 5 febbraio 2025, dopo la chiusura del mercato. L'azienda ospiterà una chiamata conferenza per gli investitori alle 14:30 ora delle Montagne (16:30 ora dell'Est) nello stesso giorno.
Gli investitori possono partecipare alla chiamata in diretta componendo il numero (877) 704-4453 dagli Stati Uniti o (201) 389-0920 a livello internazionale. Una registrazione sarà disponibile fino al 19 febbraio 2025, accessibile componendo il numero (844) 512-2921 (USA) o (412) 317-6671 (internazionale) con il codice di conferma 13750382. Una webcasting contemporanea sarà disponibile sul sito web delle Relazioni con gli Investitori dell'azienda, con un periodo di archiviazione di 30 giorni.
LifeVantage (LFVN), una empresa de salud y bienestar centrada en productos para la salud celular, ha anunciado que publicará sus resultados financieros del segundo trimestre fiscal 2025 el 5 de febrero de 2025, después del cierre del mercado. La empresa llevará a cabo una llamada de conferencia para los inversores a las 2:30 p.m. hora de las Montañas (4:30 p.m. hora del Este) ese mismo día.
Los inversores pueden participar en la llamada en vivo marcando (877) 704-4453 desde EE.UU. o (201) 389-0920 internacionalmente. Una repetición estará disponible hasta el 19 de febrero de 2025, accesible marcando (844) 512-2921 (EE.UU.) o (412) 317-6671 (internacional) con el código de confirmación 13750382. Se dispondrá de una transmisión simultánea en el sitio web de Relaciones con Inversores de la empresa, con un período de archivo de 30 días.
LifeVantage (LFVN)는 세포 건강 제품에 중점을 둔 건강 및 웰빙 회사로, 2025 회계년도 2분기 재무 결과를 2025년 2월 5일에 시장 마감 후 발표할 것이라고 발표했습니다. 회사는 같은 날 오후 2시 30분(동부 시간 오후 4시 30분)에 투자자를 위한 컨퍼런스 콜을 개최합니다.
투자자는 미국에서 (877) 704-4453 또는 국제적으로 (201) 389-0920으로 전화를 걸어 실시간 콜에 참여할 수 있습니다. 녹음된 내용은 2025년 2월 19일까지 이용 가능하며, (844) 512-2921(미국) 또는 (412) 317-6671(국제)으로 전화하여 확인 코드 13750382로 접근할 수 있습니다. 회사의 투자자 관계 웹사이트에서 동시 웹캐스트도 제공되며, 30일간 아카이브 기간이 있습니다.
LifeVantage (LFVN), une entreprise de santé et de bien-être axée sur les produits de santé cellulaire, a annoncé qu'elle publiera ses résultats financiers du deuxième trimestre de l'exercice 2025 le 5 février 2025, après la fermeture des marchés. L'entreprise organisera une conférence téléphonique pour les investisseurs à 14h30 heure des montagnes (16h30 heure de l'Est) le même jour.
Les investisseurs peuvent participer à l'appel en direct en composant le (877) 704-4453 depuis les États-Unis ou le (201) 389-0920 à l'international. Un enregistrement sera disponible jusqu'au 19 février 2025, accessible en composant le (844) 512-2921 (États-Unis) ou le (412) 317-6671 (international) avec le code de confirmation 13750382. Un webinaire simultané sera disponible sur le site web des Relations Investisseurs de l'entreprise, avec une période d'archive de 30 jours.
LifeVantage (LFVN), ein Gesundheits- und Wellnessunternehmen, das sich auf Produkte für die Zellgesundheit konzentriert, hat bekannt gegeben, dass es seine finanziellen Ergebnisse für das zweite Quartal des Geschäftsjahres 2025 am 5. Februar 2025 nach Marktschluss veröffentlichen wird. Das Unternehmen wird am selben Tag um 14:30 Uhr Mountain Zeit (16:30 Uhr Eastern Zeit) eine Telefonkonferenz für Investoren abhalten.
Investoren können an dem Live-Call teilnehmen, indem sie (877) 704-4453 aus den USA oder (201) 389-0920 international wählen. Eine Wiederholung wird bis zum 19. Februar 2025 verfügbar sein und kann unter (844) 512-2921 (USA) oder (412) 317-6671 (international) mit dem Bestätigungscode 13750382 abgerufen werden. Ein gleichzeitiger Webcast wird auf der Investor Relations-Website des Unternehmens verfügbar sein, mit einer Archivierungsdauer von 30 Tagen.
- None.
- None.
SALT LAKE CITY, Jan. 22, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its second quarter ended December 31, 2024, after the stock market closes on Wednesday, February 5, 2025. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.
Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920. A telephone replay will be available approximately two hours after the call concludes and will be available through Wednesday, February 19, 2025, by dialing (844) 512-2921 from the U.S. and entering confirmation code 13750382, or (412) 317-6671 from international locations, and entering confirmation code 13750382.
There will also be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at https://lifevantage.gcs-web.com/events-and-presentations or directly at https://viavid.webcasts.com/starthere.jsp?ei=1699720&tp_key=7be42f23a0. The webcast will be archived for approximately 30 days.
About LifeVantage Corporation
LifeVantage Corporation® (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System™, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System™, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own sales business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.
Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com
FAQ
When will LifeVantage (LFVN) release Q2 2025 earnings?
How can investors join LFVN's Q2 2025 earnings call?
Where can I watch the webcast of LFVN's Q2 2025 earnings call?
How long will LFVN's Q2 2025 earnings call replay be available?
